Cue Biopharma Inc (CUE)
1.91
-0.27
(-12.39%)
USD |
NASDAQ |
May 08, 16:00
1.91
0.00 (0.00%)
After-Hours: 20:00
Cue Biopharma Price to Book Value: 2.505 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 2.859 |
| May 06, 2024 | 2.728 |
| May 03, 2024 | 2.794 |
| May 02, 2024 | 2.466 |
| May 01, 2024 | 2.499 |
| April 30, 2024 | 2.492 |
| April 29, 2024 | 1.863 |
| April 26, 2024 | 1.790 |
| April 25, 2024 | 1.850 |
| April 24, 2024 | 1.863 |
| April 23, 2024 | 1.968 |
| April 22, 2024 | 2.059 |
| April 19, 2024 | 2.046 |
| April 18, 2024 | 2.072 |
| April 17, 2024 | 2.138 |
| April 16, 2024 | 1.961 |
| April 15, 2024 | 2.092 |
| April 12, 2024 | 2.295 |
| April 11, 2024 | 2.308 |
| April 10, 2024 | 2.328 |
| April 09, 2024 | 2.492 |
| April 08, 2024 | 2.676 |
| April 05, 2024 | 2.427 |
| April 04, 2024 | 2.335 |
| April 03, 2024 | 2.322 |
| Date | Value |
|---|---|
| April 02, 2024 | 2.387 |
| April 01, 2024 | 2.492 |
| March 28, 2024 | 2.479 |
| March 27, 2024 | 2.414 |
| March 26, 2024 | 2.414 |
| March 25, 2024 | 2.440 |
| March 22, 2024 | 2.419 |
| March 21, 2024 | 2.470 |
| March 20, 2024 | 2.521 |
| March 19, 2024 | 2.394 |
| March 18, 2024 | 2.534 |
| March 15, 2024 | 2.635 |
| March 14, 2024 | 2.584 |
| March 13, 2024 | 2.737 |
| March 12, 2024 | 2.254 |
| March 11, 2024 | 2.419 |
| March 08, 2024 | 2.521 |
| March 07, 2024 | 2.508 |
| March 06, 2024 | 2.470 |
| March 05, 2024 | 2.419 |
| March 04, 2024 | 2.572 |
| March 01, 2024 | 2.686 |
| February 29, 2024 | 2.642 |
| February 28, 2024 | 2.699 |
| February 27, 2024 | 3.005 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.374
Minimum
Sep 27 2022
19.33
Maximum
Jun 02 2020
5.156
Average
4.546
Median
Aug 20 2021
Price to Book Value Benchmarks
| Precision BioSciences Inc | 4.052 |
| NovaBay Pharmaceuticals Inc | 1.933 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7236 |
| Theriva Biologics Inc | 0.1925 |
Price to Book Value Related Metrics
| PS Ratio | 15.92 |
| Price | 1.91 |
| Earnings Yield | -58.12% |
| Market Cap | 92.91M |